Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/54917
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
Metadatos
Mostrar el registro completo del ítem
ANTIMALARIAL PYRIDO [1,2‑A] BENZIMIDAZOLES EXERT STRONG PARASITICIDAL EFFECTS BY ACHIEVING HIGH CELLULAR UPTAKE AND SUPPRESSING HEME DETOXIFICATION
Plasmodium
Benzimidazol
Parasiticida
Heme pool
Desintoxicação do heme
Plasmodium
Benzimidazole
Parasiticidal
Heme pool
Heme detoxification
Autor
Afiliación
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz, Salvador, BA, Brasil.
South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town. Rondebosch, South Africa
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz, Salvador, BA, Brasil.
Universidade de São Paulo. São Paulo, SP, Brasil.
South African Medical Research Council Drug Discovery and Development Research Uni., Department of Chemistry and Institute of Infectious Diseases and Molecular Medicine. University of Cape Town. Rondebosch, South Africa
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz, Salvador, BA, Brasil.
South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town. Rondebosch, South Africa
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz, Salvador, BA, Brasil.
Universidade de São Paulo. São Paulo, SP, Brasil.
South African Medical Research Council Drug Discovery and Development Research Uni., Department of Chemistry and Institute of Infectious Diseases and Molecular Medicine. University of Cape Town. Rondebosch, South Africa
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz, Salvador, BA, Brasil.
Resumen en ingles
Pyrido[1,2-a]benzimidazoles (PBIs) are synthetic antiplasmodium agents with potent activity and are structurally differentiated from benchmark antimalarials. To study the cellular uptake of PBIs and understand the underlying phenotype of their antiplasmodium activity, their antiparasitic activities were examined in chloroquine (CQ)-susceptible and CQ-resistant Plasmodium falciparumin vitro. Moreover, drug uptake and heme detoxification suppression were examined in Plasmodium berghei-infected mice. The in vitro potency of PBIs is comparable to most 4-aminoquinolines. They have a speed of action in vitro that is superior to that of atovaquone and an ability to kill rings and trophozoites. The antiparasitic effects observed for the PBIs in cell culture and in infected mice are similar in terms of potency and efficacy and are comparable to CQ but with the added advantage of demonstrating equipotency against both CQ susceptible and resistant parasite strains. PBIs have a high rate of uptake by parasite cells and, conversely, a limited rate of uptake by host cells. The mechanism of cellular uptake of the PBIs differs from the ion-trap mechanism typically observed for 4-aminoquinolines, although they share key structural features. The high cellular uptake, attractive parasiticidal profile, and susceptibility of resistant strains to PBIs are desirable characteristics for new antimalarial agents.
Palabras clave en portugues
MaláriaPlasmodium
Benzimidazol
Parasiticida
Heme pool
Desintoxicação do heme
Palabras clave en ingles
MalariaPlasmodium
Benzimidazole
Parasiticidal
Heme pool
Heme detoxification
Compartir